Bookmark

Add to MyYahoo RSS

BioCryst Pharmaceuticals News

News on BioCryst Pharmaceuticals (Ticker: BCRX) continually updated from thousands of sources around the net.

Thursday Jul 3 | AmericanBankingNews.com

Insider Selling: BioCryst Pharmaceuticals CFO Sells 3,125 Shares of Stock

BioCryst Pharmaceuticals CFO Thomas R. Staab II unloaded 3,125 shares of the stock on the open market in a transaction that occurred on Tuesday, July 1st.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jun 24, 2014

AmericanBankingNews.com

BioCryst Pharmaceuticals CFO Thomas R. Staab II Sells 3,125 Shares

BioCryst Pharmaceuticals CFO Thomas R. Staab II sold 3,125 shares of the company's stock in a transaction that occurred on Monday, June 23rd.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jun 23, 2014

Business Journal

BioCryst snags $1.9M for antiviral candidate

The Durham-based company, which is developing an antiviral dubbed BCX4430, had already partnered with the National Institute of Allergy and Infectious Diseases, receiving an initial award of $5 million last September.

Comment?

Related Topix: Biotech, Healthcare Industry, Infectious Diseases

Theflyonthewall.com

NIAID exercises option under agreement with BioCryst

NIAID exercises option under agreement with BioCryst BioCryst Pharmaceuticals disclosed that on June 17 the company and the National Institute of Allergy and Infectious Diseases, or NIAID, amended their agreement dated September 12, 2013 for the development of BCX4430.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Infectious Diseases

Wed Jun 04, 2014

Business Journal

Public offering yields $115M for BioCryst

Thanks to a successful public offering, Durham-based BioCryst Pharmaceuticals has some additional cash to fund accelerated testing for one of its drugs.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••